P3 Health Partners Inc.PIII
P3 Health Partners Inc. Commitments Disclosure
The Company is a party to various claims, legal and regulatory proceedings, lawsuits, and administrative actions arising in the ordinary course of business. The Company carries general and professional liability insurance coverage to mitigate the Company’s risk of potential loss in such cases. An accrual is established when a specific contingency is probable and estimable. The Company also faces contingencies that are reasonably possible to occur that cannot currently be estimated. The Company believes that disposition of these matters will not have a material adverse effect on the Company’s consolidated financial position, net loss, or cash flows. It is the Company’s policy to expense costs associated with loss contingencies, including any related legal fees, as they are incurred.
Civil Investigative Demand
In June 2024, the Company received a civil investigative demand (“CID”) from the U.S. Department of Justice (“DOJ”) pursuant to the False Claims Act in the course of the government’s investigation concerning its arrangements with insurance agents and brokers. The CID requests documentation and information relating to the marketing of the Company’s broker programs and arrangements with, and remuneration paid to, MA brokers, agents and agencies, as well as arrangements with third parties relating to these programs. The Company is cooperating with the investigation and
providing the requested information. No assurance can be given as to the timing or outcome of the government’s investigation.
Uncertainties
The healthcare industry is subject to numerous laws and regulations of Federal, state, and local governments. These laws and regulations include, but are not limited to, matters of licensure, accreditation, government healthcare program participation requirements, reimbursement for patient services, and Medicare / Medicaid Fraud, Waste and Abuse Prevention. Recently, government activity has increased with respect to investigations and allegations concerning possible violations of Fraud, Waste and Abuse statutes and regulations by healthcare providers. Violations of these laws and regulations could result in expulsion from government healthcare programs together with imposition of significant fines and penalties as well as significant repayment for patient services billed.
Management believes the Company is compliant with Fraud, Waste and Abuse regulations as well as other applicable government laws. While no regulatory inquiries have been made, compliance with such laws and regulations is subject to government review and interpretation, as well as other regulatory actions which might be unknown at this time.
Healthcare reform legislation at both the Federal and state levels continues to evolve. Changes continue to impact existing and future laws and rules. Such changes may impact the manner in which the Company conducts business, restrict the Company’s revenue growth in certain eligibility categories, slow down revenue growth rates for certain eligibility categories, increase certain medical, administrative and capital costs, and expose the Company to increased risk of loss or further liabilities. As a result, the Company’s consolidated financial position could be impacted by such changes.
Leases
The Company leases real estate in the form of corporate office space and operating facilities. The Company’s real estate leases have noncancelable terms expiring in 2026 to 2040, certain of which have one to two renewal options of to 10 years.
Operating lease right-of-use assets of $12.5 million and $12.9 million were included within on the Company’s consolidated balance sheets as of December 31, 2025 and 2024, respectively.
Operating lease costs are included within operating expenses on the consolidated statements of operations and were $4.3 million and $4.6 million for the years ended December 31, 2025 and 2024, respectively.
Lease terms and discount rates consisted of the following as of:
| December 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Weighted average remaining lease term (years) | 4.3 | 4.8 | |||||||||
| Weighted average discount rate | 12.3 | % | 12.4 | % | |||||||
Maturities of operating lease liabilities as of December 31, 2025 are as follows (in thousands):
| Year Ending December 31, | ||||||||
| 2026 | $ | 3,932 | ||||||
| 2027 | 3,691 | |||||||
| 2028 | 3,508 | |||||||
| 2029 | 3,193 | |||||||
| 2030 | 2,302 | |||||||
| Thereafter | 2,314 | |||||||
| Total undiscounted future cash flows | 18,940 | |||||||
| Less: interest | (5,027) | |||||||
| Present value of operating lease liabilities | $ | 13,913 | ||||||
The current portions of operating right-of-use liabilities of $2.4 million and $2.5 million are included in in the Company’s consolidated balance sheets as of December 31, 2025 and 2024, respectively.
Supplemental cash flows and other information related to leases are as follows:
| Year Ended December 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| (in thousands) | |||||||||||
| Operating cash flows paid for operating leases | $ | 4,190 | $ | 4,551 | |||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 26, 2026 | Showing above |
| 2024 | Mar 28, 2025 | |
| 2023 | Mar 28, 2024 | |
| 2022 | Mar 31, 2023 | |
| 2021 | Oct 21, 2022 | |
About Commitments Disclosures
Commitments and contingencies disclosures catalog a company's off-balance-sheet obligations and legal exposures — purchase commitments, guarantee arrangements, pending litigation, and regulatory proceedings. These items represent potential future cash outflows that may not appear as liabilities on the balance sheet until they become probable and estimable.
Key signals: litigation reserves and disclosed loss ranges quantify management's estimate of legal exposure, but unquantified "reasonably possible" losses often represent the larger risk. Watch for changes in language around pending cases — shifts from "remote" to "reasonably possible" or increases in estimated loss ranges signal deteriorating outcomes. Unconditional purchase obligations and take-or-pay contracts create fixed cost structures that reduce operational flexibility. Guarantee arrangements for subsidiaries or joint ventures can create cascading obligations. Compare the total commitment schedule against projected free cash flow to assess whether the company can meet its obligations without additional financing.